NEWT vs GCBC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

NEWT

61.7
AI Score
VS
NEWT Wins

GCBC

50.6
AI Score

Investment Advisor Scores

NEWT

62score
Recommendation
BUY

GCBC

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NEWT GCBC Winner
Revenue 112.38M 4.12M NEWT
Net Income 5.43M 17.48M GCBC
Net Margin 4.8% 424.7% GCBC
ROE 6.6% 15.6% GCBC
ROA 2.7% 1.4% NEWT
Total Assets 203.19M 1.27B GCBC

Relative Price Performance (Last 90 Days)

NEWT 1M: -7.5% · 3M: -21.9% GCBC 1M: -1.4% · 3M: -0.7%

Current Technical Phase

NEWT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.8%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $11.18

GCBC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.5 · Price: $34.26

Fundamentals Snapshot

Metric NEWT GCBC
Market Cap — —
Forward P/E 5.1 13.7
Trailing P/E 5.1 13.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.9% 1.0%
Operating Margin 0.5% 0.6%
EPS 2.21 2.44
Dividend Yield 0.07% 0.01%

Frequently Asked Questions

Based on our detailed analysis, NEWT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.